Navigation Links
IBT Laboratories to Launch New Pneumococcal Antibody Avidity Test at AAAAI Meeting, Booth 729
Date:3/12/2009

The Filaggrin test builds on the company's growing list of tests to investigate skin diseases. It determines whether a patient who presents with the common skin disorders atopic dermatitis or ichthyosis vugaris has a mutation that prevents the skin from working as an effective barrier to allergens and infectious agents. Current research suggests that patients with this mutation may benefit from targeted therapy. The new T-Cell Rx(TM) test assists physicians in assessing patients who have experienced a delayed drug reaction.

IBT will present two scientific posters at the conference:

  • Saturday, 9:45-10:45 am - # 41: T Cell Immunity Assessed by Intracellular Cytokine Analysis Following Stimulation of Whole Blood or PBMCs with Microbial Antigens of Mitogens
  • Sunday, 9:45-10:45 am - # 405: Presence of IgG Anti-IgE Autoantibodies in Chronic Urticaria and Atopic Dermatitis

About IBT Laboratories

A clinical diagnostic and research laboratory specializing in immunology and allergy testing, IBT tests patient samples for physicians, hospitals, and commercial reference labs nationwide. IBT also provides biomarker and immunogenicity testing services to pharmaceutical and biotechnology companies and life-science researchers. Founded in 1983, IBT is privately held and centrally located in Lenexa, Kansas, a suburb of Kansas City.

    Media contact
    Caroline Grossman
    781.771.5579
    Caroline.grossman@gmail.com


'/>"/>
SOURCE IBT Laboratories
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
2. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
3. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
4. Romark Laboratories Raises $18 Million in Institutional Financing
5. Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
6. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
7. Northfield Laboratories Inc. Presentation at FDA/NIH Workshop on Hemoglobin-Based Oxygen Carriers
8. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
9. Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders
10. Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
11. Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Pa. , Sept. 2, 2015 ... increases, diversifies revenue base with highly profitable specialty ... , Near-term growth potential with 11 product ... include Paragraph IV certifications  , Provides medium ... candidates in development, including eight controlled substances ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/275q7t/inhaled_drug ) has announced ... UK - November 19-20, 2015)" conference to their ... cover industry case studies, regulatory updates, latest therapies and ... Steven Nichols , OINP Specialist Consultant and ... Companies participating include: - Aptar Pharma ...
(Date:9/2/2015)... 2, 2015  Seeger Weiss LLP is reporting that ... commence October 13, 2015. Since the ... approval program, Zimmer NexGen knee implant surpassed FDA investigation ... companies provide evidence that the product is substantially similar ... gain permissions. In 2001, Zimmer began ...
Breaking Medicine Technology:Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 2Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 3Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 4Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 5Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 6Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015 2
(Date:9/3/2015)... ... ... Mum n Me is pleased to announce the launch of its ... maximum protection from sun exposure, wind, bugs, and germs. The Mum n Me Baby ... keeping the cover securely in place. The new car seat cover is made with ...
(Date:9/3/2015)... ... September 03, 2015 , ... At Renew Man™, we have seen an increasing ... care model, where the primary care physician dictates and the patient obeys. Instead, our ... about their health issues and empowered to choose their own treatment options. , Recognizing ...
(Date:9/3/2015)... Kingston, NY (PRWEB) , ... September 03, 2015 , ... ... on iTunes, April Hannah & Michael Habernig from Path 11 Productions have had great ... This new age podcast has featured Hay House authors, Teal Swan who is the ...
(Date:9/3/2015)... ... September 03, 2015 , ... Doctor Kayode Sotonwa ... health professionals out there. His perspective on internal medicine keeps patients happy and healthy, ... healthy is important regardless of the season, but even more so in the fall, ...
(Date:9/2/2015)... ... September 03, 2015 , ... The Aspen Clinic (TAC), ... retreats geared towards kick-starting and inspiring wellness in the Roaring Fork Valley and beyond. ... developing a whole mind-body approach to fitness - we are much more than a ...
Breaking Medicine News(10 mins):Health News:Mum n Me Announces New Baby Car Seat Cover 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 3Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2Health News:TAC Introduces New Retreats for Fall Fitness 2
... An international team of cancer specialists and imaging ... response to treatment//. The guidelines will provide clinicians ... clinical trials of lymphoma treatments and should facilitate ... guidelines developed by the International Harmonization Project (IHP) ...
... born to mothers who smoked during pregnancy may find ... study//. ,A recent animal research suggests that ... find it difficult to quit smoking. Duke University Medical ... to nicotine is known to alter areas of the ...
... insurance to around 1.2 million families below the poverty ... ,"We are aware of the health challenges and ... decided to provide health insurance to BPL families, and ... project this year," Kumaraswamy said in Ingalagi village in ...
... suffering from asthma compared to other methods of ... of different medicines. ,Although several ... clinical trials directly comparing them have not been ... ,For the first time, researchers in the Childhood ...
... Some obese have not looked up from their plate full of ... for the free obesity surgery.// ,Earlier, the government ... medical condition could get the obesity surgery done, free of cost. ... avail the free surgery offered by the government. ,People ...
... stress and depression,// may be associated with higher ... in turn are related to an increased risk for ... 22 issue of Archives of Internal Medicine, one of ... studies have linked psychosocial characteristics with cardiovascular disease and ...
Cached Medicine News:Health News:New Guidelines For Assessing Lymphoma Treatment 2Health News:New Guidelines For Assessing Lymphoma Treatment 3Health News:Quitting Not Easy for Smokers Born to Smoking Women 2Health News:Karnataka's Free Health Insurance to the Poor 2Health News:Psychosocial Factors Associated With Higher Levels of Inflammatory Markers 2
... With the increase in Endoscopic cases it is ... Monitor with the Surgical Light. This combination ... without having to adopt an uncomfortable pose. ... including the NUVO Monitoring System. As such ...
... This configuration offers all the performance of a ... perfectly for use in Outpatient Settings, Minor Procedure ... Mounting two single lights either side of the ... in a General OR when combining Flat Screen ...
A Western Blot Immunassay for the detection of antibodies to primarily anti-myelin associated glycoproteins (anti-MAG) and other glycolipid autoantibodies in human serum....
Triturus® is an open and completely automated ELISA immunoassay analyzer which can perform a variety of different tests on a series of samples and process several batches simultaneously....
Medicine Products: